TEPADINA
As listed in the register: TEPADINA
400 mg · powder for solution
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Thiotepa
- Made by
- Adienne Sa
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Thiotepa). It describes the substance, not this exact product.
Thiotepa is a cytotoxic agent of the polyfunctional type, related chemically and pharmacologically to the nitrogen mustard.
The radiomimetic action of thiotepa is believed to occur through the release of ethyleneimine radicals which, like irradiation, disrupt the bonds of DNA.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-01-23
Safety of the active substance
From the US prescribing label for the same active substance (Thiotepa). It describes the substance, not this exact product.
WARNING: SEVERE MYELOSUPPRESSION, CARCINOGENICITY.
- Thiotepa for injection is contraindicated in:.
- Patients with severe hypersensitivity to thiotepa [see Warnings and Precautions (5.2) ].
- Concomitant use with live or attenuated vaccines [see Warnings and Precautions (5.4) ].
- Hypersensitivity to the active substance.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Adienne Sa |
|---|---|
| Active substance | Thiotepa |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 400 mg |
| Form | powder for solution |
| Classification | L01AC01 · Cancer treatments and immune-system medicines |
| Route | intravenous |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Dormant |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02523906 |
| DPD drug code | 101295 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Other strengths and forms
4 products are sold under this name. Grouped by form; a number on a strength means several companies make it.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.